Picture of Unity Biotechnology logo

UNBX — Unity Biotechnology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Unity Biotechnology Inc Reports Results For The Quarter Ended In June: Earnings Summary

* UNITY Biotechnology Inc  UBX.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of -85 cents.  The mean expectation of two analysts
for the quarter was for a loss of 46 cents per share. Wall
Street expected results to range from -48 cents to -44 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * UNITY Biotechnology Inc's reported EPS for the quarter was
a
loss of 31 cents​.
    * The company reported a quarterly loss of $5.28 million.
    * UNITY Biotechnology Inc shares had held steady so far this
quarter and lost 30.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for UNITY
Biotechnology Inc is $6.00 
This summary was machine generated from LSEG data August 6 at
11:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.46          -0.31          Beat
 Mar. 31 2024      -0.48          -0.34          Beat
 Dec. 31 2023      -0.72          -0.28          Beat
 Sep. 30 2023      -0.96          -0.66          Beat

Recent news on Unity Biotechnology

See all news